Lifetree Clinical Research
has expanded its in-patient capacity from 60 to 75 beds in the early stage research unit at the 35,000-square-foot facility located at 700 E. 3838 S. in Salt Lake City, Utah. This expansion represents a greater than 100 percent increase in size since Lifetree Clinical Research was founded in 2003 at the same address as a 5,000-square-foot facility with eight beds.
The 25 percent increase in beds will allow Lifetree to conduct larger Phase I clinical research studies and support expansion into early stage research in new therapeutic areas such as experimental human models, Alzheimer’s disease, Hepatitis C, and broadened Neuropsychiatric capabilities. Despite an uncertain climate facing many of the nation’s contract research organizations, many of which reduced or eliminated bed capacity over the last four years, Lifetree continues to experience record growth and an expanding client base representing many of the nation’s leading pharmaceutical and biotech research and development companies.
Lifetree currently employs more than 100 Salt Lake City area residents in addition to other supporting personnel throughout the United States.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.